|
Vaccine Detail
P. yoelii DNA vaccine encoding PyHEP17 Protein |
Vaccine Information |
- Vaccine Name: P. yoelii DNA vaccine encoding PyHEP17 Protein
- Target Pathogen: Plasmodium spp.
- Target Disease: Malaria
- Vaccine Ontology ID: VO_0004162
- Type: DNA vaccine
- Status: Research
- HEP17
gene engineering:
- Type: DNA vaccine construction
- Description:
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0005061
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Host Strain: BALB/cByJ, A/J, B10.BR, B10.Q and C57BL/6
- Vaccination Protocol: Female 6- to 8-wk-old mice were immunized three times at 3-wk intervals intramuscularly in each tibialis anterior muscle with 50 μg of PyHEP17 DNA in 50 μl of saline or unmodified nkCMVintpolyli plasmid. 2 wk after the third immunization, mice were challenged by tail-vein injection with 100 infectious sporozoites or 200 infected erythrocytes (Doolan et al., 1996).
- Challenge Detail:
No. |
Pathogen Name |
Dose |
Route |
Age |
Interval |
1 |
Plasmodium yoelii |
100 CFU in volume ml |
Tail vein injection |
day |
14 day |
- Efficacy Detail:
No. |
Efficacy method |
Result |
Description |
Group Efficacy Detail |
1 |
In vivo protection study |
CFU |
Immunization with PyHEP17 DNA partially protected three of the five strains >20% against challenge with 100 infectious sporozoites. A 2 to 6 day delay in the onset of parasitemia in some nonprotected mice was consistent with partial immunity, which eliminated up to 90% of infected hepatocytes (Doolan et al., 1996). |
|
|
References |
Doolan et al., 1996: Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. The Journal of experimental medicine. 1996; 183(4); 1739-1746. [PubMed: 8666931].
|
|